Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A tripla ® is a branded, combination once-daily tablet recommended as first-line anti-retroviral therapy (ART) for HIV in the United States (containing tenofovir-emtricitabine-efavirenz).

Updates

By Carol A. Kemper, MD, FACP